Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dong Soo, Ham"'
Autor:
Sue-Kyoung Jo, Seon-Young Yang, Suchada Chinaworapong, Jiwook Park, Dong Soo Ham, Edison Alberto, Sushant Sahastrabuddhe, Jean-Louis Excler, Arijit Sil, Yun Chon, Maria Rosario Capeding, Ju Yeon Park, Jerome H. Kim, T. Anh Wartel, Julia Lynch, Deok Ryun Kim, Jae Seung Yang, Samuel Teshome, Ji Hwa Ryu, Tarun Saluja, Hun Kim
Publikováno v:
Vaccine
Highlights • Vi-DT is safe and well tolerated in infants and toddlers aged 6–23 months. • Vi-DT showed >1000-fold higher Geometric Mean Titer (GMT) compared to Placebo. • 100% seroconversion reported in Vi-DT group in all age strata.
Bac
Bac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ab1674b1c2c0490128ef8d71f8550d7
https://doi.org/10.1016/j.vaccine.2019.09.074
https://doi.org/10.1016/j.vaccine.2019.09.074
Autor:
Maria Rosario, Capeding, Samuel, Teshome, Tarun, Saluja, Khalid Ali, Syed, Deok Ryun, Kim, Ju Yeon, Park, Jae Seung, Yang, Yang Hee, Kim, Jiwook, Park, Sue-Kyoung, Jo, Yun, Chon, Sudeep, Kothari, Seon-Young, Yang, Dong Soo, Ham, Ji Hwa, Ryu, Hee-Seong, Hwang, Ju-Hwan, Mun, Julia A, Lynch, Jerome H, Kim, Hun, Kim, Jean-Louis, Excler, Sushant, Sahastrabuddhe
Publikováno v:
Vaccine. 36(26)
Typhoid fever remains a major public health problem in low- and middle-income countries where children aged 2-14 years bear the greatest burden. Vi polysaccharide is poorly immunogenic in children2 years of age, and protection in adults is modest. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::58248342f570dadf7f13219e438d3f98
https://pubmed.ncbi.nlm.nih.gov/29776750
https://pubmed.ncbi.nlm.nih.gov/29776750